Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: Implications for treatment

European Journal of Medical Research

Volumn 15, Issue 2, 2010, Pages 27-35

  Demkow, Urszula ^a   Van Overveld, Frans J ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Immunologist   (Belgium)

Author keywords

antiproteinases; COPD; metalloproteinases; neutrophil elastase; pathogenesis; treatment

Indexed keywords

3 ACETOXYMETHYL 2 (2 CARBOXY 1 PYRROLIDINYLCARBONYL) 7ALPHA METHOXY 8 OXO 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE 5,5 DIOXIDE; ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CATHEPSIN G; CHLOROMETHYLKETONE; COLLAGENASE 3; CORTICOSTEROID; ELASTASE; ELASTASE INHIBITOR; FORMOTEROL; GELATINASE A; INTERSTITIAL COLLAGENASE; LODELABEN; MACROPHAGE ELASTASE; METALLOPROTEINASE; MYELOBLASTIN; OXYGEN; SALMETEROL; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SIVELESTAT; THEOPHYLLINE; TIOTROPIUM BROMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; [4 (4 BROMOPHENYLSULFONYLCARBAMOYL)BENZOYL]VALYLPROLINE N (2 METHYL 1 TRIFLUOROACETYLPROPYL)AMIDE; MATRIX METALLOPROTEINASE; PANCREATIC ELASTASE; SLPI PROTEIN, HUMAN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENZYME ACTIVITY; HUMAN; INFLAMMATION; LUNG EMPHYSEMA; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SMALL AIRWAY DISEASE; ENZYMOLOGY; PHYSIOLOGY;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; MATRIX METALLOPROTEINASES; PANCREATIC ELASTASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;

EID: 79952277134     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-15-S2-27     Document Type: Review

References (129)

1. Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, Brewer MT, Thompson RC, Crystal RG: Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest 1991, 87: 2207-15. 10.1172/JCI115255
2. Ayad MS, Knight KR, Burdon JGW, Brenton S: Secretory leukocyte proteinase inhibitor, alpha-1-antitrypsin deficiency and emphysema: Preliminary study, speculation and an hypothesis. Respirology 2003, 8: 175-80. 10.1046/j.1440-1843.2003.00463.x
3. Babusyte A, Stravinskaite K, Jeroch J, Lötvall J, Sakalauskas R, Sitkauskiene B: Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res 2007, 8: 81. 10.1186/1465-9921-8-81
4. Barrett AJ: Leukocyte elastase. Methods Enzymol 1981, 80: 581-8.
5. Belvisi MG, Bottomley KM: The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): A therapeutic role for inhibitors of MMPs? Inflamm Res 2003, 52: 95-100. 10.1007/s000110300020
6. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D: Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999, 160: 1248-53.
7. Boudier C, Bieth JG: Oxidized mucus proteinase inhibitor: A fairly potent neutrophil elastase inhibitor. Biochem J 1994, 303: 61-8.
8. Brantly M, Nukiwa T, Crystal RG: Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1998, 84: 13-31.
9. Bruch M, Bieth JG: Influence of elastin on the inhibition of leuco cyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J 1986, 238: 269-73.
10. Burdon JGW, Knight KR, Brenton S, Cook L: Antiproteinase deficiency, emphysema and replacement therapy. Aust NZ J Med 1996, 26: 769-71. 10.1111/j.1445-5994.1996.tb00622.x
11. Burnett D, Abrahamson M, Devalia JL, Sapsford RJ, Davies RJ, Buttle DJ: Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch Biochem Biophys 1995, 317: 305-10. 10.1006/abbi.1995.1167
12. Campbell EJ, Campbell MA, Boukedes SS, Owen CA: Quantum proteolysis by neutrophils: Implications for pulmonary emphysema in alpha 1-antitrypsin deficiency. J Clin Invest 1999, 104: 337-44. 10.1172/JCI6092
13. Campbell EJ, Senior RM, Welgus HG: Extracellular matrix injury during lung inflammation. Chest 1987, 92: 161-7. 10.1378/chest.92.1.161
14. Cao Z, Henzel WJ, Gao X: IRAK: A kinase associated with the interleukin-1 receptor. Science 1996, 271: 1128-31. 10.1126/science.271.5252.1128
15. Chang YP, Mahadeva R, Chang WS, Shukla A, Dafforn TR, Chu YH: Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z alpha1-antitrypsin. Am J Respir Cell Mol Biol 2006, 35: 540-8. 10.1165/rcmb.2005-0207OC
16. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R: Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006, 27: 188-207. 10.1183/09031936.06.00024505
17. Chrystyn H, Mulley BA, Peake MD: Dose response relation to oral theophylline in severe chronic obstructive airways disease. Br Med J 1988, 297: 1506-10. 10.1136/bmj.297.6662.1506
18. Chung KF: Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001, 34: 50s-9s.
19. Churg A, Dai J, Tai H, Xie C, Wright JL: Tumor necrosis factor-alpha is central to acute cigarette smoke induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002, 166: 849-54. 10.1164/rccm.200202-097OC
20. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, Shapiro SD, Wright JL: Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003, 167: 1083-9. 10.1164/rccm.200212-1396OC
21. Churg A, Wang RD, Xie C, Wright JL: Alpha-1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2003, 168: 199-207. 10.1164/rccm.200302-203OC
22. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL: Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004, 170: 492-8. 10.1164/rccm.200404-511OC
23. Churg A, Wang X, Wang RD, Meixner SC, Pryzdial EL, Wright JL: Alpha 1-Antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol 2007, 37: 144-51. 10.1165/rcmb.2006-0345OC
24. Crystal RG: The alpha-1-antitrypsin gene and its deficiency states. Trends Genet 1989, 5: 411-7.
25. Davies M, Barrett AJ, Travis J, Sanders E, Coles GA: The degradation of human glomerular basement membrane with purified lysosomal proteinases: Evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin Sci Mol Med 1978, 54: 233-40.
26. De Backer WA, Amsel B, Jorens PG, Bossaert L, Hiemstra PS, van Noort P, van Overveld FJ: N-Acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid. Intensive Care Med 1996, 22: 900-8. 10.1007/BF02044114
27. de Serres FJ: Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002, 122: 1818-29. 10.1378/chest.122.5.1818
28. Decramer M, Rutten-van Mölken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer WA, Lankhorst I, Ardia A: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial. Lancet 2005, 365: 1552-60. 10.1016/S0140-6736(05)66456-2
29. Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, Pauwels RA, Brusselle GG: Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006, 61: 196-201. 10.1136/thx.2005.042432
30. Eriksson S: Studies in alpha 1-antitrypsin deficiency. Acta-Med Scand 1965, 432: 1-85.
31. Fagerholm MK, Laurell CB: The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera. Clin Chim Acta 1967, 16: 199-203. 10.1016/0009-8981(67)90181-7
32. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG: Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995, 152: 1666-72.
33. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, Fitzgerald MX, O'Connor CM: Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997, 156: 240-7.
34. Fitch PM, Roghanian A, Howie SEM, Sallenave JM: Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 2006, 34: 279-82. 10.1042/BST20060279
35. Gadek JE, Fells GA, Wright DG, Crystal RG: Human neutrophil elastase functions as a type III collagen "collagenase". Biochem Biophys Res Commun 1980, 95: 1815-22. 10.1016/S0006-291X(80)80110-0
36. Ganrot PO: Variation of the alpha-2-macroglobulin homologue with age in some mammals. Scand J Clin Lab Invest 1968, 21: 177-81. 10.3109/00365516809084280
37. Geraghty P, Rogan MP, Greene CM, Boxio RM, Poiriert T, O'Mahony M, Belaaouaj A, O'Neill SJ, Taggart CC, McElvaney NG: Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J Immunol 2007, 178: 5871-8.
38. Gettins PG: Serpin structure, mechanism, and function. Chem Rev 2002, 102: 4751-804. 10.1021/cr010170+
39. Gronski TJ Jr, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD: Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 1997, 272: 12189-94. 10.1074/jbc.272.18.12189
40. Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF: Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis 1989, 140: 1188-91.
41. Gross P, Pfitzer EA, Tolker E, Babyak MA, Kaschak M: Experimental emphysema: Its production with papain in normal and silicotic rats. Arch Environ Health 1965, 11: 50-8.
42. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42: 773-8. 10.1136/thx.42.10.773
43. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: Systematic review and meta-analysis. Eur Respir J 2006, 28: 523-32. 10.1183/09031936.06.00124605
44. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997, 277: 2002-4. 10.1126/science.277.5334.2002
45. Higgins BG, Powell RM, Cooper S, Tattersfield AE: Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J 1991, 4: 415-20.
46. Hill AT, Bayley DL, Campbell EJ, Hill SL, Stockley RA: Airways inflammation in chronic bronchitis: The effects of smoking and alpha-1-antitrypsin deficiency. Eur Respir J 2000, 15: 886-90. 10.1034/j.1399-3003.2000.15e12.x
47. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA: Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha-1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999, 160: 1968-75.
48. Hoidal JR: Genetics of COPD: Present and future. Eur Respir J 2001, 18: 741-3. 10.1183/09031936.01.00268501
49. Hollander C, Westin U, Wallmark A, Piitulainen E, Sveger T, Janciauskiene SM: Plasma levels of alpha-1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha-1-antitrypsin deficiency. BMC Pulm Med 2007, 7: 1. 10.1186/1471-2466-7-1
50. Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, D'Armiento J: Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001, 163: 786-91.
51. Janciauskiene SM, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T: Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha-1-antitrypsin. Biochem Biophys Res Commun 2004, 321: 592-600. 10.1016/j.bbrc.2004.06.123
52. Janciauskiene SM, Nita IM, Stevens T: Alpha-1-antitrypsin, old dog, new tricks. Alpha-1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 2007, 282: 8573-82. 10.1074/jbc.M607976200
53. Janoff A, Sloan B, Weinbaum G, Damiano V, Sandhaus RA, Elias J, Kimbel P: Experimental emphysema induced with purified human neutrophil elastase: Tissue localization of the instilled protease. Am Rev Respir Dis 1977, 115: 461-78.
54. Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164: 28S-38.
55. Kalsheker N, Morley S, Morgan K: Gene regulation of the serine proteinase inhibitors alpha-1-antitrypsin and alpha-1-antichymotrypsin. Biochem Soc Trans 2002, 30: 93-8.
56. Köhnlein T, Welte T: Alpha-1-antitrypsin deficiency: Pathogenesis, clinical presentation, diagnosis, and treatment. Am J Med 2008, 121: 3-9. 10.1016/j.amjmed.2007.07.025
57. Kueppers F, Miller RD, Gordon H, Hepper NG, Offord KP: Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977, 63: 336-42. 10.1016/0002-9343(77)90270-4
58. Kueppers F, Utz G, Simon B: Alpha1-antitrypsin deficiency with M-like phenotype. J Med Genet 1977, 14: 183-6. 10.1136/jmg.14.3.183
59. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T: Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption. Endocrinology 1998, 139: 1338-45. 10.1210/en.139.3.1338
60. Laurell CB, Eriksson S: The electrophoretic alpha-1-globulin pattern of serum alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963, 15: 132-40.
61. Lowrey GE, Henderson N, Blakey JD, Corne JM, Johnson SR: MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med 2008, 102: 845-51. 10.1016/j.rmed.2008.01.006
62. Luisetti M, Seersholm N: Alpha-1-antitrypsin deficiency. I: Epidemiology of alpha-1-antitrypsin deficiency. Thorax 2004, 59: 164-9. 10.1136/thorax.2003.006494
63. MacNee W: Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2007, 28: 479-513. 10.1016/j.ccm.2007.06.008
64. McCawley LJ, Matrisian LM: Matrix metalloproteinases: They're not just for matrix anymore. Curr Opin Cell Biol 2001, 13: 534-40. 10.1016/S0955-0674(00)00248-9
65. McDonald JA, Kelley DG: Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem 1980, 255: 8848-58.
66. Mehran RJ, Deslauriers J: Indications for surgery and patient work-up for bullectomy. Chest Surg Clin N Am 1995, 5: 717-34.
67. Molet S, Belleguic C, Lena H, Germain N, Bertrand CP, Shapiro SD, Planquois JM, Delaval P, Lagente V: Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005, 54: 31-6. 10.1007/s00011-004-1319-4
68. Morrison HM, Kramps JA, Burnett D, Stockley RA: Lung lavage fluid from patients with alpha-1-proteinase inhibitor deficiency or chronic obstructive bronchitis: Antielastase function and cell profile. Clin Sci 1987, 72: 373-81.
69. Nadel JA: Role of mast cell and neutrophil proteases in airway secretion. Am Rev Respir Dis 1991, 144: S48-S51.
70. Nagasawa H, Sasaki H, Uto Y, Kubo S, Hori H: Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein. Anticancer Res 2004, 24: 3361-6.
71. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, Fishman AP, National Emphysema Treatment Trial Research Group: Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006, 82: 431-43. 10.1016/j.athoracsur.2006.05.069
72. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM: Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004, 41: 14895-900.
73. Nita I, Hollander C, Westin U, Janciauskiene SM: Prolastin, a pharmaceutical preparation of purified human alpha-1antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res 2005, 6: 12. 10.1186/1465-9921-6-12
74. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1980, 93: 391-8.
75. Ofulue AF, Ko M: Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol 1999, 277: L97-L105.
76. Ohlsson K, Tegner H: Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest 1976, 36: 437-45. 10.3109/00365517609054461
77. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT: Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998, 78: 1077-87.
78. Ongagna JC, Pinget M, Belcourt A: Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes. Clin Biochem 2005, 38: 415-9. 10.1016/j.clinbiochem.2004.12.013
79. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS, GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD). Workshop Summary. Am J Respir Crit Care Med 2001, 163: 1256-76.
80. Petty TL: The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 1990, 97: 75-83. 10.1378/chest.97.1.75
81. Poller W, Barth J, Voss B: Detection of an alteration of the alpha-2-macroglobulin gene in a patient with chronic lung disease and serum alpha-2-macroglobulin deficiency. Hum Genet 1989, 83: 93-6. 10.1007/BF00274157
82. Postma DS, Boezen HM: Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004, 126: 96S-104S. 10.1378/chest.126.2-suppl-1.96S
83. Report of the Medical Research Council Working Party: Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981, 1: 681-6.
84. Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG: Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis 2004, 190: 1245-53. 10.1086/423821
85. Roughley PJ, Barrett AJ: The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis. Biochem J 1977, 167: 629-37.
86. Russell RE, Culpitt SV, de Matos C, Donnelly L, Smith M, Wiggins J, Barnes PJ: Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002, 26: 602-9.
87. Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G, Fabbri LM: Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbation of chronic bronchitis. Clin Exp Allergy 1996, 26: 766-74. 10.1111/j.1365-2222.1996.tb00606.x
88. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, Fabbri LM: Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994, 150: 1646-52.
89. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157: 822-6.
90. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM: Cellular and structural bases of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001, 163: 1304-9.
91. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J: Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994, 11: 733-41.
92. Sallenave JM, Si Tahar M, Cox G, Chignard M, Gauldie J: Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 1997, 61: 695-702.
93. Sampsonas F, Karkoulias K, Kaparianos A, Spiropoulos K: Genetics of chronic obstructive pulmonary disease, beyond alpha-1-antitrypsin deficiency. Curr Med Chem 2006, 13: 2857-73. 10.2174/092986706778521922
94. Sandford AJ, Joos L, Pare PD: Genetic risk factors for chronic obstructive pulmonary disease. Curr Opin Pulm Med 2002, 8: 87-94. 10.1097/00063198-200203000-00002
95. Sandford AJ, Silverman EK: Chronic obstructive pulmonary disease. I: Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002, 57: 736-41. 10.1136/thorax.57.8.736
96. Senior RM, Bielefeld DR, Starcher BC: Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase. Biochem Biophys Res Commun 1976, 72: 1327-34. 10.1016/S0006-291X(76)80160-X
97. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, Mignatti P: Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: A role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 2001, 189: 197-206. 10.1002/jcp.10014
98. Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160: S29-S32.
99. Shapiro SD: Animal models for chronic obstructive pulmonary disease. Age of klotho and marlboro mice. Am J Respir Cell Mol Biol 2000, 22: 4-7.
100. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A: Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 2003, 163: 2329-35. 10.1016/S0002-9440(10)63589-4
101. Siafakas NM, Tzortzaki EG: Few smokers develop COPD. Why? Respir Med 2002, 96: 615-24. 10.1053/rmed.2002.1318
102. Sinha S, Watorek W, Karr S, Giles J, Bode W, Travis J: Primary structure of human neutrophil elastase. Proc Natl Acad Sci USA 1987, 84: 2228-32. 10.1073/pnas.84.8.2228
103. Snider GL: Understanding inflammation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2003, 167: 1045-6. 10.1164/rccm.2302002
104. Snider GL, Lucey EC, Christensen TG, Stone PJ, Calore JD, Catanese A, Franzblau C: Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am Rev Respir Dis 1984, 129: 155-60.
105. Snider GL, Lucey EC, Stone PJ: Animal models of emphysema. Am Rev Respir Dis 1986, 133: 149-69.
106. Snider GL, Stone PJ, Lucey EC, Breuer R, Calore JD, Seshadri T, Catanese A, Maschler R, Schnebli HP: Eglin-c, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia in the hamster. Am Rev Respir Dis 1985, 132: 1155-61.
107. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH: Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990, 85: 682-9. 10.1172/JCI114492
108. Starkey PM, Barrett AJ, Burleigh MC: The degradation of articular collagen by neutrophil proteinases. Biochem Biophys Acta 1977, 483: 386-97. 10.1016/0005-2744(77)90066-3
109. Steinberg J, Fink G, Picone AL, Searles B, Schiller H, Lee HM, Nieman G: Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J Extra Corpor Technol 2001, 33: 218-22.
110. Stewart RJ, Marsden PA: Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade. Am J Kidney Dis 1995, 25: 954-66. 10.1016/0272-6386(95)90582-0
111. Stockley RA: Proteolytic enzymes, their inhibitors and lung diseases. Clin Sci 1983, 64: 119-26.
112. Stockley RA, Bayley DL, Unsal I, Dowson LJ: The effect of augmentation therapy on bronchial inflammation in alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 2002, 165: 1494-8. 10.1164/rccm.2109013
113. Stoller JK, Aboussouan LS: Alpha-1-antitrypsin deficiency. Lancet 2005, 365: 2225-36. 10.1016/S0140-6736(05)66781-5
114. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, O'Neill S, McElvaney NG: Inactivation of beta-defensins 2 and 3 by elastolytic cathepsins. J Immunol 2003, 171: 931-7.
115. Takahashi H, Nukiwa T, Basset P, Crystal RG: Myelomonocytic cell lineage expression of the neutrophil elastase gene. J Biol Chem 1988, 263: 2543-7.
116. Tegner H: Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol 1978, 85: 282-9.
117. Tetley TD: Proteinase imbalance: Its role in lung disease. Thorax 1993, 48: 560-5. 10.1136/thx.48.5.560
118. The COMBIVENT Inhalation Solution Study Group: Routine nebulized ipratropium and albuterol together are better than either alone in COPD. Chest 1997, 112: 1514-21.
119. Tunstall AM, Merriman JM, Milne I, James K: Normal and pathological serum levels of alpha 2-macroglobulins in men and mice. J Clin Pathol 1975, 28: 133-9. 10.1136/jcp.28.2.133
120. van Overveld FJ, Demkow UA, Gorecka D, De Backer WA, Zielinski J: New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine. J Physiol Pharmacol 2005, 56: 135-42.
121. Vathenen AS, Britton JR, Ebden P, Cookson JB, Wharrad HJ, Tattersfield AE: High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis 1988, 138: 850-5. 10.1164/ajrccm/138.4.850
122. Vignola AM, Bonanno A, Mirabella A, Riccobono L, Mirabella F, Profita M, Bellia V, Bousquet J, Bonsignore G: Increased levels of elastase and alpha-1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998, 157: 505-11.
123. Vogelmeier C, Hubbard RC, Fells GA, Schnebli HP, Thompson RC, Fritz H, Crystal RG: Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991, 87: 482-8. 10.1172/JCI115021
124. Williams SE, Brown TI, Roghanian A, Sallenave JM: SLPI and elafin: One glove, many fingers. Clin Sci 2006, 110: 21-35. 10.1042/CS20050115
125. Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, Nusbaum P, Ueki I, Canteloup S, Lenoir G, Descamps-Latscha B, Nadel JA: Proteinase-3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol 1999, 20: 729-36.
126. Wright JL, Churg A: Current concepts in mechanisms of emphysema. Toxicol Pathol 2007, 35: 111-5. 10.1080/01926230601059951
127. Yoshida T, Tuder RM: Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007, 87: 1047-82. 10.1152/physrev.00048.2006
128. Zhang J, Kew RR: Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function. J Biol Chem 2004, 279: 53282-7. 10.1074/jbc.M411462200
129. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA: Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000, 106: 1081-93. 10.1172/JCI10458